Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 4/20 | 0.43 |
| ▸ | CA1 | P00915 | 4/20 | 0.43 |
| ▸ | CA2 | P00918 | 4/20 | 0.43 |
| ▸ | CA9 | Q16790 | 4/20 | 0.43 |
| ▸ | HPRT1 | P00492 | 3/20 | 0.38 |
| ▸ | HSD17B1 | P14061 | 2/20 | 0.37 |
| ▸ | HSD17B2 | P37059 | 2/20 | 0.37 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.37 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.36 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.36 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.35 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.35 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.35 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.35 |
| ▸ | ESR1 | P03372 | 1/20 | 0.35 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.35 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25088882 | 0.97 | CA12 (0.42) | CA12CA1CA2CA9HPRT1 | |
| SCHEMBL25088791 | 0.96 | CA1 (0.39) | CA12CA1CA2CA9HPRT1 | |
| SCHEMBL22669932 | 0.96 | CA12 (0.42) | CA12CA1CA2CA9HSD17B1 | |
| SCHEMBL25088247 | 0.96 | CA1 (0.39) | CA12CA1CA2CA9HPRT1 | |
| SCHEMBL21203605 | 0.96 | CA12 (0.45) | CA12CA1CA2CA9HSD17B1 | |
| SCHEMBL21203689 | 0.95 | CA12 (0.44) | CA12CA1CA2CA9HSD17B1 | |
| SCHEMBL25088794 | 0.95 | CA12 (0.44) | CA12CA1CA2CA9HPRT1 | |
| SCHEMBL22671838 | 0.95 | CA12 (0.43) | CA12CA1CA2CA9HPRT1 | |
| SCHEMBL22671882 | 0.95 | CA12 (0.43) | CA12CA1CA2CA9HPRT1 | |
| SCHEMBL12159641 | 0.94 | CA12 (0.44) | CA12CA1CA2CA9HDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210359223-A1 | ORGANIC LIGHT-EMITTING ELEMENT | LG CHEM, LTD. (KR) | 2021-11-18 | — | — | US | disclosed |
| EP-3832745-A1 | ORGANIC LIGHT-EMITTING ELEMENT | LG Chem, Ltd. (KR) | 2021-06-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210359223-A1 | ORGANIC LIGHT-EMITTING ELEMENT | LAS1L, ARL1, NAP1L4 | CA12 1397/4885CA1 1427/4885CA2 1807/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.